Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9729 - 9736 of 11616 results
Do Not Pass Go: Federal Judge Orders Execs Jailed for Contempt of Recall Order
September 16, 2014| Blog| Viewpoint
ML Strategies Energy & Environment Update: Week of 9/15/2014
September 16, 2014| Blog| Viewpoint
What 2014’s Continued IPO Surge Means for Clean Tech and Renewable Energy Companies
September 16, 2014| Article| Viewpoint
Employment Law Summer Recap 2014
September 15, 2014| Blog| Viewpoint
Employment Law Summer Recap 2014: Part 1 of 11 - FedEx sings Nico & Vinz’s “Am I Wrong”…to Classify Our Drivers as Independent Contractors?
September 15, 2014| Blog| Viewpoint
Another Court Rules That Availability of Make-Whole Premiums in Bankruptcy Depends on Governing Documents
September 15, 2014| Advisory| Viewpoint
Is a Global Settlement Agreement on the Horizon for Solar Trade Issues?
September 15, 2014| Article| Viewpoint
Cap Gap Expiration Approaching: Some Employees' Work Authorization May End on October 1, 2014
September 12, 2014| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.